Insperity, Inc. (NSP) EPS Estimated At $0.75; Abbvie (ABBV)’s Sentiment Is 0.85

January 15, 2018 - By Peter Erickson

Analysts expect Insperity, Inc. (NYSE:NSP) to report $0.75 EPS on February, 12.They anticipate $0.30 EPS change or 66.67% from last quarter’s $0.45 EPS. NSP’s profit would be $31.27M giving it 19.68 P/E if the $0.75 EPS is correct. After having $0.94 EPS previously, Insperity, Inc.’s analysts see -20.21% EPS growth. The stock decreased 0.84% or $0.5 during the last trading session, reaching $59.05. About 128,966 shares traded. Insperity, Inc. (NYSE:NSP) has risen 13.05% since January 15, 2017 and is uptrending. It has underperformed by 3.65% the S&P500.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company has market cap of $160.19 billion. The firm offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It has a 24.37 P/E ratio. It also provides Kaletra, an anti- human immunodeficiency virus-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 EPS, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28B for 17.54 P/E if the $1.43 EPS becomes a reality. After $1.41 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Ratings analysis reveals 25% of AbbVie’s analysts are positive. Out of 4 Wall Street analysts rating AbbVie, 1 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $70.0 while the high is $82.0. The stock’s average target of $76 is -24.26% below today’s ($100.34) share price. ABBV was included in 4 notes of analysts from September 2, 2016. The rating was downgraded by Credit Suisse to “Neutral” on Monday, October 31. Raymond James initiated the stock with “Outperform” rating in Friday, September 2 report. JP Morgan downgraded the shares of ABBV in report on Thursday, September 8 to “Neutral” rating. The firm earned “Mkt Perform” rating on Tuesday, October 18 by Leerink Swann.

Brandywine Trust Co holds 12.83% of its portfolio in AbbVie Inc. for 161,371 shares. Orbis Investment Management (U.S.) Llc owns 165,798 shares or 9.17% of their US portfolio. Moreover, Inspirion Wealth Advisors Llc has 9.09% invested in the company for 201,742 shares. The Iowa-based United Fire Group Inc has invested 6.73% in the stock. Hendershot Investments Inc., a Virginia-based fund reported 148,802 shares.

Since January 1, 0001, it had 0 insider purchases, and 8 insider sales for $45.57 million activity.

The stock increased 1.08% or $1.07 during the last trading session, reaching $100.34. About 4.37M shares traded. AbbVie Inc. (ABBV) has risen 10.63% since January 15, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Insperity, Inc. provides human resources and business solutions to enhance business performance for small and medium-sized businesses in the United States. The company has market cap of $2.46 billion. The firm offers its HR business services through its Workforce Optimization and Workforce Synchronization solutions, which encompasses a range of human resources functions comprising benefits and payroll administration, health and workers?? compensation insurance programs, personnel records management, employer liability management, assistance with government compliance, general HR advice, employee recruiting and support, employee performance management, and training and development services. It has a 31.78 P/E ratio. It also provides Employee Service Center, a cloud human capital management platform that provides automated and personalized professional employer organization HR outsourcing solutions to its clients and worksite employees; and Workforce Administration solution that offers human capital management and payroll services.

Since August 1, 2017, it had 0 insider buys, and 13 sales for $9.57 million activity. $4.33M worth of stock was sold by RAWSON RICHARD G on Tuesday, August 1. 600 shares were sold by Michelle McKenna, worth $47,814. $212,500 worth of Insperity, Inc. (NYSE:NSP) was sold by ARIZPE ARTHUR A on Monday, August 7. 3,000 shares were sold by Herink Daniel D, worth $250,020. 5,742 shares valued at $482,615 were sold by SARVADI PAUL J on Wednesday, August 16. Another trade for 2,459 shares valued at $207,871 was sold by MINCKS JAY E. $41,925 worth of Insperity, Inc. (NYSE:NSP) shares were sold by MORPHY JOHN M.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts